Intraglandular Treatment With Adipose-derived Mesenchymal Stem Cells in Patients With Xerostomia Due to Sjögren's Disease

Clinical trial NCT06805448 · RECRUITING

Trial details

NCT number: NCT06805448
Sponsor: Rigshospitalet, Denmark
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Sjorgren's Syndrome

Start date: 2025-01-21
Primary completion: 2025-12-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.